Management of drug resistant gestational trophoblastic neoplasia

Journal of Reproductive Medicine for the Obstetrician and Gynecologist

Volumn 55, Issue 7-8, 2010, Pages 296-300

  Patel, Shilpa M ^a   Desai, Ava ^a  

^a GUJARAT CANCER AND RESEARCH INSTITUTE   (India)

Author keywords

Drug resistance; Gestational trophoblastic neoplasia; Secondline treatment

Indexed keywords

BLEOMYCIN; CHORIONIC GONADOTROPIN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; ETOPOSIDE; FOLINIC ACID; IFOSFAMIDE; METHOTREXATE; VINCRISTINE; ANTINEOPLASTIC AGENT; CHORIONIC GONADOTROPIN BETA SUBUNIT;

ARTICLE; BRAIN METASTASIS; CANCER COMBINATION CHEMOTHERAPY; CANCER MORTALITY; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; FEMALE; FOLLOW UP; HORMONE BLOOD LEVEL; HUMAN; MAJOR CLINICAL STUDY; OUTCOME ASSESSMENT; PATIENT SELECTION; PRIORITY JOURNAL; PROGNOSIS; RADIATION DOSE; SALVAGE THERAPY; TROPHOBLASTIC TUMOR; ADULT; BLOOD; DRUG RESISTANCE; METASTASIS; MORTALITY; PATHOLOGY; PREGNANCY; RETROSPECTIVE STUDY; UTERUS CANCER;

ADULT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHORIONIC GONADOTROPIN, BETA SUBUNIT, HUMAN; CISPLATIN; CYCLOPHOSPHAMIDE; DACTINOMYCIN; DRUG RESISTANCE, NEOPLASM; ETOPOSIDE; FEMALE; GESTATIONAL TROPHOBLASTIC NEOPLASMS; HUMANS; IFOSFAMIDE; LEUCOVORIN; METHOTREXATE; NEOPLASM METASTASIS; PREGNANCY; RETROSPECTIVE STUDIES; UTERINE NEOPLASMS; VINCRISTINE;

EID: 77957271891     PISSN: 00247758     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Lurain JR, Nejad B: Secondary chemotherapy for high-risk gestational trophoblastic neoplasia. Gynecol Oncol 2005;97: 618-623
2. Lurain JR, Elfstrand EP: Single-agent methotrexate chemotherapy in treatment of non-metastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1995;172:574-579
3. Roberts JP, Lurain JR: Treatment of low-risk metastatic gestational trophoblastic tumors. Am J Obstet Gynecol 1996;174: 1917-1924
4. Hammond CB, Borchert LG: Treatment of metastatic trophoblastic disease: Good and poor prognosis. Am J Obstet Gynecol 1973;115:451-457
5. Gordon AN, Gershenson DM: High risk metastatic disease: Further stratification into two clinical entities. Gynecol Oncol 1989;34:54-56
6. DuBeshter B, Berkowitz RS, Goldstein DP, Bernstein MR: Analysis of treatment failure in high risk metastatic gestational trophoblastic disease. Gynecol Oncol 1988;29:199-207
7. McNeish IA, Strickland S, Holden L, et al: Low-risk persistent gestational trophoblastic disease: Outcome after initial treatment with low-dose methotrexate and folinic acid from 1992-2000. J Clin Oncol 2002;20:1838-1844
8. Berkowitz RS, Goldstein DP: Presentation and management of persistent gestational trophoblastic disease and gestational trophoblastic tumors in the USA. In Gestational Trophoblastic Disease. Edited by BW Hancock, ES Newlands, RS Berkowitz. London, Chapman & Hall, 1997, pp 159-172
9. Newlands ES, Bagshawe KD, Begent RHJ, et al: Results with EMA-CO (etoposide, methotrexate, actinomycin D, cyclophosphamide, vincristine) regime in high risk gestational trophoblastic tumors (1979-1989). BJOG 1991;98:550-557
10. Bower M, Newlands ES, Holden L, et al: EMA-CO for highrisk gestational tumors; results from a cohort of 271 patients. J Clin Oncol 1997;15:2636-2643
11. Kim SJ, Bae SN, Kim JH, et al: Risk factors for the prediction of treatment failure in gestational trophoblastic tumors treated with EMA/CO regimen. Gynecol Oncol 1998;71: 247-253
12. Escobar PF, Lurain JR, Singh DK, et al: Treatment of highrisk gestational trophoblastic neoplasia with etoposide, methotrexate, actinomycin D, cyclophosphamide and vincristine chemotherapy. Gynecol Oncol 2003;91:552-557
13. Newlands ES, Mulholland PJ, Holden L, et al: Etoposide and cisplatin/etoposide, methotrexate and actinomycin D (EMA) chemotherapy for patients with high-risk gestational trophoblastic tumors refractory to EMA/cyclophosphamide and vincristine and patients presenting with metastatic placental site trophoblastic tumors. J Clin Oncol 2000;18:854-859
14. Sutton GP, Soper JT, Blessing JA, et al: Ifosfamide alone and in combination in the treatment of refractory malignant gestational trophoblastic disease. Am J Obstet Gynecol 1992; 167:489-493
15. Garris PD, Gallup DG, Melton K: Long-term remission of previously resistant choriocarcinoma with a combination of etoposide, ifosfamide and cisplatin. Gynecol Oncol 1995;57: 254-256
16. Lurain JR, Casanova LA, Miller DS, et al: Prognostic factors in gestational trophoblastic tumors. Am J Obstet Gynecol 1991;64:611-616
17. Agrawal R, Strickland S, McNeish IA, et al: Doppler ultrasonography of the uterine artery and the response to chemotherapy in patients with gestational trophoblastic tumors. Clin Cancer Res 2002;8:1142-1147
18. Lim AKP, Agrawal R, Barrett N, et al: Embolisation of residual uterine vascular malformations in patients with gestational trophoblastic tumors. Radiology 2002;222:640-644